| HS Code | 922032 |
| Product Name | Act3302 Inactivated Bacteria Raw Material |
| Bacterial Type | Lactobacillus plantarum |
| Inactivation Method | Heat treatment |
| Physical Form | Powder |
| Color | Off-white to light yellow |
| Odor | Characteristic, mild |
| Solubility | Dispersible in water |
| Purity | ≥98% |
| Moisture Content | ≤7% |
| Storage Conditions | Cool, dry place, tightly sealed |
| Shelf Life | 24 months |
| Intended Use | Cosmetic and skincare formulations |
| Country Of Origin | China |
| Allergenic Status | Non-allergenic |
As an accredited Act3302 Inactivated Bacteria Raw Material factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The Act3302 Inactivated Bacteria Raw Material is packaged in a sealed 500-gram white HDPE bottle with secure tamper-evident cap. |
| Shipping | The shipping of `Act3302 Inactivated Bacteria Raw Material` requires secure, temperature-controlled packaging to preserve product integrity. It must be transported in compliance with biosafety regulations, accompanied by relevant documentation. Ensure containers are properly sealed and labeled, and handle with care to prevent contamination or spillage during transit. |
| Storage | **Act3302 Inactivated Bacteria Raw Material** must be stored in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible materials. Maintain temperatures between 2–8°C, unless otherwise specified on the product label. Ensure containers are tightly sealed to prevent contamination. Store in dedicated biological storage facilities according to biosafety and local regulatory guidelines. |
Competitive Act3302 Inactivated Bacteria Raw Material prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing biological raw materials isn’t just a recipe of fermenters, media, and sterile lines—it comes down to stubborn attention to details at every processing step. In our years producing Act3302 Inactivated Bacteria Raw Material, the messiness of real-world challenges showed us what customers actually need from a practical perspective. Every batch meant tuning strain management and fermentation controls, listening to the feedback from our customers after they trialed the product, then taking those suggestions back to our technical teams. Through this effort, we’ve shaped Act3302 into an inactivated bacteria material designed specifically for modern fermentation starters, direct-feed microbial blends, and agricultural biologicals where the living status of the strain might hinder handling or stability.
Choosing inactivated over active materials is not a switch people make lightly, especially in microbial-based products. Years ago, frustrated customers talked about inconsistent shelf stability and short usable windows for "live" bacteria, which easily spoiled in adverse storage or during transport. Active strains had their place in probiotics, but the application space asking for bacteria bodies, cell-wall fragments, and metabolites—not just viable cells—grew larger every season. Act3302 stepped in for these applications: feed, fertilizer, soil remediation, and sometimes even cosmetic actives, where stable, safe, and easy-to-store raw material could offer a practical edge.
People on the manufacturing floor remember the long lead times and batch inconsistencies of earlier generations of inactivated bacteria. That is why the process behind Act3302 focuses on minimizing batch-to-batch deviation. We rely on a single strain lineage, grown under carefully recorded fermentation parameters, then inactivated using controlled temperature and pressure—not chemicals that might compromise downstream safety. Routine QC confirms the microbial count is truly inactivated (often well below one colony-forming unit per gram), while protein and cell debris content fit real-world requirements.
Handling dry powders is rarely neat. Early attempts at inactivating bacteria sometimes left clumpy, hydrophobic powders which resisted dispersal—problems anyone scaling up an industrial process can appreciate. We overhauled drying and milling for Act3302 to target consistent dispersibility. It flows well, both into blending kettles and into tablet or pellet formulations, and doesn’t resist wet-out. The dry powder stores under ambient warehouse conditions without caking or odor issues that plague many biologicals. We learned the hard way with pilot lots that sticking to old spray-drying curves from the feed sector didn’t get it done, so our process engineer ran batch after batch to dial in the profile. The fine-tuning finally gave us material that matches modern process expectations.
Farmers and agronomists are increasingly looking for biostimulant effects, not just classic NPK or synthetic pesticides. What Act3302 brings to these formulations is a matrix of microbial cell-wall fragments, exopolysaccharides, and residual metabolites—features known to stimulate plant immune pathways, add organic nutrition, and contribute to soil health, all while avoiding the risks of living bacterial contamination in the finished products. Unlike living probiotics where cold storage may be the only way to preserve viability, manufacturers relax with Act3302; the bioactive fractions remain effective over long timeframes, eliminating the logistics burden tied to temperature-sensitive materials.
In animal feed supplements, Act3302 sees frequent use for non-viable microbial support. End-users want products rich in microbial cell walls—especially peptidoglycan and lipoteichoic acid—that have shown gut-health benefits and can modulate immune response, without triggering regulatory hurdles sometimes associated with introducing live cultures into regulated feed chains. In our work with major additive houses, Act3302 consistently met the target specs for these bioactive components. We avoid unnecessary processing aids and use traceable media inputs, important for producers who need to document the full ingredient trace for certifications.
Act3302 arrives as a tan, free-flowing powder with moisture content consistently below 7%—that’s not just an arbitrary number, but the result of dozens of stability runs that established where clumping or spoilage popped up. The inactivation method leaves the core cell structures intact; that matters if customers need to verify morphology under microscopic inspection, for QA or regulatory review. Cell concentration typically exceeds 1x1010 bacterial particles per gram, measured by direct microscopy, not plate count, since these cells are no longer viable. Protein content hovers in the 20%-25% region, a key range for bio-stimulant and feed supplement formulations. We spend extra effort on microbial purity testing—each lot gets full panel residue and contaminant screens, not just standard aerobic plate counts.
Some clients request granulated forms for easier dosing; our technical team developed a rolling agglomeration process that retains the activity of key cell-wall fractions while dramatically reducing fine particulate loss during transport. For wet-blend applications, like biostimulant concentrates for soil injection, a pre-hydrated slurry option makes it easier to dose into tanks. These formats emerged from practical feedback, not marketing copy, after collaborating with both multinational blenders and small-batch pilot plants.
Every operator knows the pain of a powder that dusts everywhere, refuses to pour, bridges in feeders, or gums up when water hits it. During development, we regularly sent out trial shipments in full-volume drums. Only after input from customers hauling material across variable climates, or storing in rural warehouses without climate control, did we tweak bulk anti-caking and drum liner practices. Our packing line team redesigned inner bagging to reduce static charge, making sure Act3302 pours cleanly without sticking or build-up. The product stays stable without refrigeration since inactivation goes down to a cellular level, not just surface sterilization.
Real process reliability also depends on the comfort of both plant crew and product developers working with a biological raw material. Our workers appreciate a powder that doesn’t leave strong odors hanging in the air or compound dust on surfaces. That’s why our air-scrubber plans consider off-gas produced during drying, and we regularly rotate HEPA filters on the packaging line—simple factory interventions, but the kind that keep people and production lines in better shape.
Active (or live) bacteria materials still have their place in specialty fermentation, probiotics for human or animal use, and certain high-value fertilizer amendments. The challenge lies in their fragility. Our teams used to handle live cultures destined for sensitive fermentation runs, with all the complications: short transport windows, temperature drops shutting growth down, sudden loss of cfu (colony-forming units) that left customers angry when shelf life came up short. With Act3302, the risk of outgrowth, cross-contamination, or downtime from batch spoilage drops practically to zero. There’s a relief for quality assurance teams—no need to run constant viability counts during storage or worry about compliance with local or national regulations regarding live microbial material.
From a practical perspective, manufacturers report far fewer complaints tied to product failure when moving away from live bacterial powders. The inactivated product also simplifies international shipping documentation. Plenty of countries have strict rules about importing living cultures. Act3302 sidesteps these bottlenecks, speeding up customs clearance and reducing spoilage claims from stuck shipments. We learned through our own exports which paperwork hitches matter: biologicals flagged at ports, or delayed because customs officials demanded data on strain identity and viable counts. Providing documentation for inactivated material proved much smoother, both in Asia and in North America.
Product developers want both predictability and flexibility. In real-world blending tanks, Act3302 disperses without forming stubborn aggregates—something that came from optimizing bulk density, not just particle size distribution charts. It works well in both dry premixes and liquid blends, letting manufacturers design a range of application methods from seed coatings to water-dispersible biofertilizer concentrates.
We’ve seen firsthand how granule or pellet makers benefit: the powder compresses evenly, moisture doesn’t cause uneven binding or surface sweating, and it incorporates quickly into common feed or soil amendment bases without generating off-smells. Big blenders asked for a material compatible with both organic and conventional product lines—so our regulatory and QC teams eliminated any inputs or media outside permitted lists and documented every step. Whether the goal involves inclusion in OMRI-listed organic products or just passing basic agricultural certification, Act3302 provided the documentation producers need during audits.
Raw material consistency affects everything downstream. We learned to measure not just what’s in the bag, but how it behaves from the moment it hits a client’s mixer. There’s a difference between hitting a certain protein or particle count in the final QC sheet and achieving trouble-free handling in a commercial plant with automated feeders or low-pressure pump lines.
Feedback from our partner facilities showed that a product passing all in-house metrics mattered less if the mixing technician struggled with dosing or noticed variability between pallets. That’s why we maintain close controls on inactivation endpoints. Regular plant reviews checked for unexpected shifts in fermentation performance, and that culture-line purity did not stray over long campaigns. The same foreman who managed scale-up now oversees bulk packout and runs cross-checks on both process and quality control.
To keep refining our process, we sit down with formulating teams and look at how Act3302 performed in specific use-cases. Did the powder stay flowable in high-humidity storage? Did it wet out evenly in their proprietary liquid bases? Could their analytical lab recover the necessary cell components for their claims? Incorporating their points meant modifying batch drying profiles or minor tweaks to carrier blends; no one knows practical headaches like the end user.
With a complex biological raw material, traceability strings matter more than industry buzzwords. Full batch control—from the parent culture’s freezer record through each fermentation lot—led us to adopt a strict batch log system early on. In case a customer needs to track a raw material for certification or regulatory registration, quick access to every step on our side provides real value.
We test Act3302 lots using both in-house and third-party labs, especially for residue and biological purity. The push for transparency is no passing trend—numerous countries now demand full disclosure of inputs, especially for products destined for organic farming or those carrying claims about absence of GMOs, antibiotics, or allergenic media inputs. Proudly, our team fields these documentation requests every season, compiling records that go back over a decade.
Safe manufacturing is rooted in both plant standards and attention on the ground. During scale-up trials, unexpected risks pop up—like airborne microbial dust or gloves that trap moisture during mixing. Our safety routines improved by listening to the people actually packaging and handling Act3302: switching to engineered local exhausts, redesigning bag mouth closures, and adding simple dehumidifiers in bulk packing zones. Factory teams use basic powder-handling PPE, while product managers get safety data prepared using standardized local and international risk assessment formats.
Getting a consistent inactivated material took years of process tweaks. Fermentation sometimes drifted unpredictably due to temperature spikes, so our team invested in new control loops and better culture-seeding protocols. Inactivation once left partial survivors; only daily full-panel micro checks convinced us our process hit the right endpoint. At one point, material arriving at a client’s plant clumped from excess humidity on the truck. We responded by reviewing warehouse and transport handoffs, training drivers, and using better inner liners.
Shipping over long distances, especially by container, sometimes softened drum tops or allowed minor ingress. Now, every outbound pallet faces a temperature and humidity logging test during the hot and rainy season. Customers get advice for warehouse storage picked up from our own on-site lessons.
Buyers and technical teams push for more than just a COA—they want to know about upstream inputs, how inactivation is validated, and what sort of documentation comes with every shipment. We built internal protocols for raw material documentation, including archived samples and digital batch records linked to every outgoing batch. Product teams trust that we’ll disclose detail when inspections or customer audits come up.
On top of that, field teams regularly check with customers for follow-up: how the powder handled, if it met performance expectations, and whether they discovered any unexpected changes while using it in their process. There’s no shortcut to maintaining credibility: real answers and practical support matter more than generic boilerplate.
Act3302 Inactivated Bacteria Raw Material grew out of countless hours on fermenter platforms, drying lines, and QC benches—not from generic product sheets or third-party claims. Honest feedback shapes every improvement. Teams demand a microbial raw material that works on the factory floor, survives global logistics, and fits real applications from modern agriculture to emerging biologics. The pathway from bench scale to bulk delivery remains a human story—every tweak born from operator insights, every improvement sharpened by hands-on handling.
Meeting the ongoing demands for transparent, reliable, and stable bacterial derivatives means continuous investment in both people and process control. We’ve walked through the missteps and worked out the bottlenecks, always with a mind to what our downstream partners ask for—consistency, safety, and value they can measure. From raw culture to finished powder, Act3302 reflects what happens when manufacturers keep hands on the process and minds open to what actually matters for today’s bio-based industries.